Thorvardur R Halfdanarson (Thorvardur Halfdanarson)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Topics

Neuroendocrine Tumors

Top Venues

JCO precision oncology

JCO oncology practice

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Amye J Tevaarwerk, Dhauna P Karam, Clare A Gatten, Elizabeth S Harlos, Matthew John Maurer, Karthik V Giridhar, Tufia C Haddad, Steven R Alberts, Sara J Holton, Abigail Stockham, Konstantinos Leventakos, Joleen M Hubbard, Aaron S Mansfield, Thorvardur R Halfdanarson, Ruqin Chen, Jacob A Jochum, Anna S Schwecke, Rachel A Eiring, Jamie L Carroll, Irbaz Bin Riaz, Robert R McWilliams, Evanthia Galanis, Sumithra J Mandrekar
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot. Cancer (2024)
Aakash Desai, Alexander H Xiao, Daheui Choi, Merih Deniz Toruner, Daniel Walden, Thorvardur R Halfdanarson, Steven Alberts, Robert R McWilliams, Amit Mahipal, Daniel Ahn, Hani Babiker, Gulnaz Stybayeva, Alexander Revzin, Sani Kizilbash, Alex Adjei, Tanios Bekaii-Saab, Aaron S Mansfield, Ryan M Carr, Wen Wee Ma
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Cancers 16 (10) (2024)
Aakash Desai, Alexander H Xiao, Daheui Choi, Merih Deniz Toruner, Daniel Walden, Thorvardur R Halfdanarson, Steven Alberts, Robert R McWilliams, Amit Mahipal, Daniel Ahn, Hani Babiker, Gulnaz Stybayeva, Alexander Revzin, Sani Kizilbash, Alex Adjei, Tanios Bekaii-Saab, Aaron S Mansfield, Ryan M Carr, Wen Wee Ma
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Cancers 16 (10) (2024)
Yael N Kusne, Terra Lasho, Christy Finke, Zaid Elsabbagh, Shaylene McCue, Timothy J Hobday, Jason S Starr, Tanios S Bekaii-Saab, Thorvardur R Halfdanarson, Mirinal S Patnaik, Fang-Shu Ou, Mohamad Bassam B Sonbol
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study. JCO precision oncology 8 (2024)
Harry E Fuentes Bayne, Pashtoon Murtaza Kasi, Li Ma, Lowell L Hart, Jenna Wong, David R Spigel, Catherine A Schnabel, James A Reeves, Thorvardur R Halfdanarson, Kai Treuner, F Anthony Greco
Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary. JCO precision oncology 8 (2024)
Albert Jang, Ayse Tuba Kendi, Geoffrey B Johnson, Thorvardur R Halfdanarson, Oliver Sartor
Targeted Alpha-Particle Therapy: A Review of Current Trials. International journal of molecular sciences 24 (14) (2023)
Sandra Algarin-Perneth, Riham Suleiman, Jithma P Abeykoon, Thorvardur R Halfdanarson, Harry E Fuentes-Bayne, Joanne E Yi, Tobias Peikert, Patrick W McGarrah
Deep and Repeated Response to Trastuzumab Deruxtecan in a Patient With Human Epidermal Growth Factor Receptor 2-Amplified Large-Cell Neuroendocrine Carcinoma With Brain Metastases: A Case Report. JCO precision oncology 7 (2023)
Jaydira Del Rivero, Kimberley J Perez, Erin B Kennedy, Erik S Mittra, Namrata Vijayvergia, Junaid Arshad, Sandip Basu, Aman Chauhan, Arvind N Dasari, Andrew M Bellizzi, Alexandra Gangi, Erin Grady, James R Howe, Jana Ivanidze, Mark Lewis, Josh Mailman, Nitya Raj, Heloisa P Soares, Michael C Soulen, Sarah B White, Jennifer A Chan, Pamela L Kunz, Simron Singh, Thorvardur R Halfdanarson, Jonathan R Strosberg, Emily K Bergsland
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Leonidas N Diamantopoulos, Markos Kalligeros, Thorvardur R Halfdanarson, Nikolaos Diamantis, Christos Toumpanakis
Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies. Biology 12 (8) (2023)
Brian J Burkett, David J Bartlett, Patrick W McGarrah, Akeem R Lewis, Derek Richard Johnson, Kezban Berberoğlu, Mukesh K Pandey, Annie T Packard, Thorvardur R Halfdanarson, Carrie B Hruska, Geoffrey B Johnson, Ayse Tuba Kendi
A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements. Radiology. Imaging cancer 5 (4) (2023)
Nikolaos Andreatos, Patrick W McGarrah, Mohamad Bassam Sonbol, Jason S Starr, Jaume Capdevila, Halfdan Sorbye, Thorvardur R Halfdanarson
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment. Current oncology reports (2023)
Thorvardur R Halfdanarson, Nadine Mallak, Scott Paulson, Chandrikha Chandrasekharan, Mona Natwa, Ayse Tuba Kendi, Hagen F Kennecke
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy. Cancers 15 (19) (2023)
Amro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, Jennifer A Yonkus, Jennifer L Leiting, Isaac T Lynch, Alessandro Fogliati, Nellie A Campbell, Danielle M Carlson, Lewis Rowland Roberts, Gregory J Gores, Rory L Smoot, Rondell P Graham, Thorvardur R Halfdanarson, Mark J Truty
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States. Cancers 15 (3) (2023)
Amro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, Jennifer A Yonkus, Jennifer L Leiting, Isaac T Lynch, Alessandro Fogliati, Nellie A Campbell, Danielle M Carlson, Lewis Rowland Roberts, Gregory J Gores, Rory L Smoot, Rondell P Graham, Thorvardur R Halfdanarson, Mark J Truty
Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States. Cancers 15 (3) (2023)
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, Michael G Haddock, Shaker R Dakhil, Robert J Behrens, Steven R Alberts
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma. The oncologist 27 (7) (2022)
Joshua C Pritchett, Bijan J Borah, Aakash P Desai, Zhuoer Xie, Antoine N Saliba, Konstantinos Leventakos, Jordan D Coffey, Kristina K Pearson, Leigh L Speicher, Robert Orenstein, Abinash Virk, Ravindra Ganesh, Jonas Paludo, Thorvardur R Halfdanarson, Tufia C Haddad
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19. JCO oncology practice 17 (9) (2021)
Shrunjal Shah, Rohit Gosain, Adrienne Groman, Rahul Gosain, Arvind Dasari, Thorvardur R Halfdanarson, Sarbajit Mukherjee
Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States. Cancers 13 (8) (2021)
Jennifer Jane Gile, Fang-Shu Ou, Amit Mahipal, Joseph J Larson, Kabir Mody, Zhaohui Jin, Joleen M Hubbard, Thorvardur R Halfdanarson, Steven R Alberts, Aminah Jatoi, Robert R McWilliams, Wen Wee Ma, Sumera Ilyas, Rory Smoot, Lewis Rowland Roberts, Gregory Gores, Mitesh J Borad, Tanios S Bekaii-Saab, Nguyen H Tran
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience. JCO precision oncology 5 (2021)
Hallbera Gudmundsdottir, Rondell P Graham, Mohamad Bassam B Sonbol, Rory L Smoot, Mark J Truty, Michael L Kendrick, David M Nagorney, Elizabeth B Habermann, Thorvardur R Halfdanarson, Sean P Cleary
Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors. Journal of surgical oncology 124 (7) (2021)
Mohamad B Sonbol, Thorvardur R Halfdanarson
Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-Letter. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (10) (2020)
Urshila Durani, Dennis Asante, Herbert C Heien, Carrie A Thompson, Thorvardur R Halfdanarson, Lindsey Sangaralingham, Prema Peethambaram, Fernando J Quevedo, Jose C Villasboas Bisneto, Ronald S Go
Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely Recommendations. JCO oncology practice 17 (4) (2020)
Jason S Starr, Mohamad Bassam B Sonbol, Timothy J Hobday, Akash Sharma, Ayse Tuba Kendi, Thorvardur R Halfdanarson
Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights. OncoTargets and therapy 13 (2020)
Brian J Burkett, Ayca Dundar, Jason R Young, Annie T Packard, Geoffrey B Johnson, Thorvardur R Halfdanarson, Rachel A Eiring, Denise N Gansen, Cynthia M Patton, Ayse Tuba Kendi
How We Do It: A Multidisciplinary Approach to 177Lu DOTATATE Peptide Receptor Radionuclide Therapy. Radiology 298 (2) (2020)
Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M Kuderer, Chih-Yuan Hsu, Samuel M Rubinstein, Brendan J Lee, Toni K Choueiri, Gilberto de Lima Lopes, Petros D Grivas, Corrie A Painter, Brian I Rini, Michael A Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B Doroshow, Pamela C Egan, Dimitrios Farmakiotis, Leslie A Fecher, Christopher R Friese, Matthew D Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R Halfdanarson, Balazs Halmos, Jessica E Hawley, Ali Raza Khaki, Christopher A Lemmon, Sanjay Mishra, Adam J Olszewski, Nathan A Pennell, Matthew M Puc, Sanjay G Revankar, Lidia Schapira, Andrew Schmidt, Gary K Schwartz, Sumit A Shah, Julie Tsu-Yu Wu, Zhuoer Xie, Albert C Yeh, Huili Zhu, Yu Shyr, Gary H Lyman, Jeremy L Warner, null null
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer discovery 10 (10) (2020)